The effects of increased central serotonergic activity on psychophysiological parameters of human information processing.

Trial Profile

The effects of increased central serotonergic activity on psychophysiological parameters of human information processing.

Completed
Phase of Trial: Phase II

Latest Information Update: 16 Sep 2011

At a glance

  • Drugs Escitalopram (Primary)
  • Indications Depressive disorders; Generalised anxiety disorder; Obsessive-compulsive disorders; Panic disorder
  • Focus Pharmacodynamics
  • Most Recent Events

    • 30 Apr 2011 Results published in the Psychiatry Research.
    • 24 Mar 2009 Additional lead trial centres identified as reported by ClinicalTrials.gov.
    • 19 Sep 2006 Status change
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top